Regulatory Harmonization: A Roadmap for Digital Diagnostics
How are evolving FDA and EMA guidelines shaping market entry? The regulatory path for digital pathology has historically been complex, particularly for primary diagnosis. However, recent shifts toward a more unified framework have lowered the barriers for entry. Understanding these nuances is critical for investors and developers who need to navigate the transition from "research use only"...
0 Yorumlar 0 hisse senetleri 11 Views 0 önizleme